| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b16ed016cd688bc2a7f35298dc64c63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03d95e0e27e432732adeefc7323e25c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74be70be6013bcc4b0812a085c6dface
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13896c8714e18bff65ce1285ab51afcd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
| filingDate |
2006-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70e630152678fcfcceafe818b2dd64a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_224139c85ef3ade4da9e78c988a8eead
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a7f428a341c717ac304f4670129a880
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79811504e8999867409f5fe7023f974c |
| publicationDate |
2007-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007117159-A1 |
| titleOfInvention |
Receptor for B. anthracis toxin |
| abstract |
The present invention relates to mammalian anthrax toxin receptor polypeptides and polynucleotides encoding same as well as related polypeptides and polynucleotides, vectors containing the polynucleotides and polypeptides, host cells containing related polynucleotide molecules, and cells displaying no anthrax toxin receptor on an exterior surface of the cells-minus cell lines and animals. The present invention also relates to methods for identifying molecules that bind the anthrax toxin receptor and molecules that reduce the toxicity of anthrax toxin. Finally, the present invention provides methods for treating human and non-human animals suffering from anthrax. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005196407-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7435418-B2 |
| priorityDate |
2000-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |